Arkema stock holds firm as buyback activity underpins valuation
Published on 08/26/2026 at 13:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Arkema (FR0010313833) stock is changing hands in the high €50s on Euronext Paris on August 26, 2026, with intraday quotes showing prices around €58.65 and a modest gain versus the previous session per recent market data. The latest readings indicate a 52-week performance in the mid-teens in percentage terms, signaling that investors who held the shares through 2026 have seen double-digit gains despite volatility in European equities.
Buyback activity and trading in own shares
Recent disclosures filed on August 25, 2026, highlight that Arkema has been actively repurchasing its own shares between August 17 and August 21, 2026, as documented in a trading-in-own-shares notice on the Euronext platform Arkema trading in own shares disclosure on Euronext. Such programs reduce the free float and can support earnings per share over time when the share count declines.
According to a recent stock overview that consolidates price and performance metrics Arkema stock overview with intraday quote and performance data, the shares traded at €58.65 on August 26, 2026, up 0.51% at the latest intraday update, with a session high of €58.75 and a low of €58.40. That same snapshot points to a year-to-date gain of more than 13%, aligning Arkema with the stronger names in the European specialty chemicals space in 2026.
Earnings profile and recent half-year trends
Arkema’s most recent financial reporting cycle, covering the first half of 2026, showed that the group continues to generate a substantial revenue base in advanced materials and specialty chemicals, even as global demand patterns remain mixed. Recent financial-portal coverage summarizing the latest interim results reports that Arkema generated several billion euros of revenue in H1 2026, with operating profitability supported by pricing discipline and portfolio reshaping toward higher-margin activities.
Within that H1 2026 framework, Arkema’s earnings profile reflects a combination of volume-driven growth in selected segments and continued cost-control efforts across the portfolio. Market commentary notes that, compared with the prior-year period, Arkema managed to stabilize or slightly improve key profitability metrics such as operating margins, even though headline revenue growth was more muted as the company cycled a strong 2025 base.
Investors are focusing on how Arkema’s H1 2026 performance sets up the rest of the year, particularly in light of management’s medium-term ambitions for higher returns in advanced materials and a more balanced geographic mix. The H1 2026 numbers, together with ongoing portfolio adaptation, suggest that Arkema continues to navigate input-cost inflation and end-market uncertainty without a major deterioration in its profit structure.
Valuation context and comparison with broader indices
In valuation terms, Arkema’s stock-level performance during 2026 can be compared with broader French and European benchmarks that have delivered modest single-digit gains so far this year. An index overview for a broad French equity benchmark CAC All-Tradable index data and components overview shows that the CAC All-Tradable index stood at 6,288.82 points on August 26, 2026, up 3.66% from the start of the year. Against that backdrop, Arkema’s low-teens year-to-date percentage gain implies that the stock has outperformed the broader French market in 2026 by several percentage points.
The combination of a share price around €58.65 and a year-to-date gain above 13% as of late August 2026 places Arkema’s performance between defensive consumer names and more cyclical industrials. For investors, the gap between Arkema’s mid-teens stock return and a roughly 3.66% gain for the broad French index illustrates a positive relative-performance spread of more than 9 percentage points in 2026.
From a technical perspective, recent quote histories indicate that Arkema has traded close to €60 per share during several sessions in August 2026, with intraday highs in that region followed by modest pullbacks Arkema share price history and daily performance data. That behavior suggests that the €60 level functions as a short-term reference point in the current trading range, even if not a formal resistance line.
Advanced materials and specialty chemicals offering
Arkema has increasingly positioned itself as a leading player in advanced materials and specialty chemicals, moving away from purely commodity products. The company’s portfolio includes high-performance polymers, adhesives, coatings, and other specialty solutions used across automotive, construction, electronics, packaging, and renewable energy applications. Recent product-focused communications emphasize Arkema’s role in supplying materials that support lower-carbon technologies and more durable end products, aligning with customer demand for sustainable solutions.
In practice, that means Arkema provides materials that can help reduce weight in vehicles, improve the efficiency of wind turbines, or extend the life of infrastructure assets, which in turn supports downstream customers’ decarbonization and cost-saving goals. For investors, the growing share of revenue from advanced materials and high-value specialty segments matters because these activities tend to carry higher margins and more resilient demand patterns than traditional bulk chemicals.
Arkema stock price context
Arkema’s primary listing is on Euronext Paris, where the shares trade in euros under the ticker AKE. Based on intraday market data as of August 26, 2026, Arkema stock was quoted at €58.65, with an intraday gain of 0.51% and a daily trading range between €58.40 and €58.75 Latest Arkema quote and intraday data on Euronext Paris. That price sits slightly below recent levels around €60 recorded in mid-August 2026, suggesting a modest consolidation after a period of strength earlier in the year.
Read more
Go deeper into Arkema’s stock performance, buyback disclosures, and latest financial metrics via the recent overview and regulatory filings available through market-data platforms and exchange-based disclosure systems.
Investor Relations
Further details on Arkema’s strategy, segment mix, and financial targets can be found in the company’s investor relations materials, including presentations and interim reports, which provide additional context for how management plans to balance growth, profitability, and shareholder returns.
Fact box
Company: Arkema S.A.
ISIN: FR0010313833
Ticker: AKE
Exchange: Euronext Paris
Price (as of August 26, 2026, 11:54 a.m. local time): €58.65
Market cap: not specified in available data
Sector / Industry: Specialty chemicals and advanced materials
Index membership: CAC All-Tradable
